Early Palliative Care in Advanced Non-Small Cell Lung Cancer Patients: A Meta-Analysis.

Jie Liu, Wei Cheng, Jie Du, Yamin Li
{"title":"Early Palliative Care in Advanced Non-Small Cell Lung Cancer Patients: A Meta-Analysis.","authors":"Jie Liu, Wei Cheng, Jie Du, Yamin Li","doi":"10.1177/10499091241300530","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aims to assess the efficacy of Early Palliative Care (EPC) in non-small cell lung cancer (NSCLC) through a meta-analysis approach.</p><p><strong>Methods: </strong>A computerized search was conducted in databases such as PubMed, Cochrane Library, Scopus, Embase, and Web of Science for prospective randomized controlled trials (RCTs) investigating the application of EPC in advanced NSCLC. Outcome measures including Overall Survival (OS), quality of life, and psychological status were extracted and subjected to pooled analysis.</p><p><strong>Results: </strong>After the computerized search, a total of 7 studies comprising 1185 participants were included, with 597 patients receiving EPC intervention and 588 patients receiving Standard Care (SC) intervention. Three studies reported OS after the intervention, demonstrating a significant improvement in OS for patients receiving EPC (pooled HR = 1.60, 95% CI: 1.22, 1.98). Five studies analyzed the Functional Assessment of Cancer Therapy (FACT) scores after the intervention, revealing a significant improvement in FACT scores for patients receiving EPC (pooled SMD = 1.18, 95% CI: 1.04, 1.31). No significant differences were found in anxiety and depression scores between the 2 interventions in the 5 studies.</p><p><strong>Conclusion: </strong>In advanced NSCLC, EPC provides benefits in terms of increased survival rates and improved quality of life. EPC should be considered as part of multidisciplinary treatment for patients with advanced NSCLC.</p>","PeriodicalId":94222,"journal":{"name":"The American journal of hospice & palliative care","volume":" ","pages":"10499091241300530"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The American journal of hospice & palliative care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/10499091241300530","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This study aims to assess the efficacy of Early Palliative Care (EPC) in non-small cell lung cancer (NSCLC) through a meta-analysis approach.

Methods: A computerized search was conducted in databases such as PubMed, Cochrane Library, Scopus, Embase, and Web of Science for prospective randomized controlled trials (RCTs) investigating the application of EPC in advanced NSCLC. Outcome measures including Overall Survival (OS), quality of life, and psychological status were extracted and subjected to pooled analysis.

Results: After the computerized search, a total of 7 studies comprising 1185 participants were included, with 597 patients receiving EPC intervention and 588 patients receiving Standard Care (SC) intervention. Three studies reported OS after the intervention, demonstrating a significant improvement in OS for patients receiving EPC (pooled HR = 1.60, 95% CI: 1.22, 1.98). Five studies analyzed the Functional Assessment of Cancer Therapy (FACT) scores after the intervention, revealing a significant improvement in FACT scores for patients receiving EPC (pooled SMD = 1.18, 95% CI: 1.04, 1.31). No significant differences were found in anxiety and depression scores between the 2 interventions in the 5 studies.

Conclusion: In advanced NSCLC, EPC provides benefits in terms of increased survival rates and improved quality of life. EPC should be considered as part of multidisciplinary treatment for patients with advanced NSCLC.

晚期非小细胞肺癌患者的早期姑息治疗:一项 Meta 分析。
研究目的本研究旨在通过荟萃分析法评估早期姑息治疗(EPC)对非小细胞肺癌(NSCLC)的疗效:方法:在PubMed、Cochrane Library、Scopus、Embase和Web of Science等数据库中进行计算机检索,寻找研究EPC在晚期NSCLC中应用的前瞻性随机对照试验(RCT)。提取的结果指标包括总生存期(OS)、生活质量和心理状态,并进行汇总分析:经过计算机检索,共纳入7项研究,1185名参与者,其中597名患者接受了EPC干预,588名患者接受了标准护理(SC)干预。三项研究报告了干预后的OS,显示接受EPC干预的患者OS显著改善(汇总HR = 1.60,95% CI:1.22,1.98)。五项研究分析了干预后的癌症治疗功能评估(FACT)评分,结果显示,接受 EPC 治疗的患者的 FACT 评分有显著改善(汇总 SMD = 1.18,95% CI:1.04, 1.31)。在5项研究中,两种干预方法在焦虑和抑郁评分方面没有发现明显差异:结论:对于晚期 NSCLC 患者,EPC 可提高生存率并改善生活质量。EPC应被视为晚期NSCLC患者多学科治疗的一部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信